日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Streptomyces coelicolor UPF0098 protein SCO1794 (SCO1794) CSB-YP893537FOB
CSB-EP893537FOB
CSB-BP893537FOB
CSB-MP893537FOB
CSB-EP893537FOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces coelicolor Transaldolase 2 (tal2) CSB-YP893538FOB
CSB-EP893538FOB
CSB-BP893538FOB
CSB-MP893538FOB
CSB-EP893538FOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces coelicolor NADH-quinone oxidoreductase subunit D 2 (nuoD2) CSB-YP893539FOB
CSB-EP893539FOB
CSB-BP893539FOB
CSB-MP893539FOB
CSB-EP893539FOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP893540RKN
CSB-EP893540RKN
CSB-BP893540RKN
CSB-MP893540RKN
CSB-EP893540RKN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant DNA-binding protein HU (hup) CSB-YP893541SML
CSB-EP893541SML
CSB-BP893541SML
CSB-MP893541SML
CSB-EP893541SML-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Protein RecA (recA) CSB-YP893542RLU
CSB-EP893542RLU
CSB-BP893542RLU
CSB-MP893542RLU
CSB-EP893542RLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus 30S ribosomal protein S2 (rpsB) CSB-YP893543BQN
CSB-EP893543BQN
CSB-BP893543BQN
CSB-MP893543BQN
CSB-EP893543BQN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Rubredoxin (rub) CSB-YP893544BYN
CSB-EP893544BYN
CSB-BP893544BYN
CSB-MP893544BYN
CSB-EP893544BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacillus stearothermophilus Alpha-N-arabinofuranosidase (abfA), partial CSB-YP893545GFM
CSB-EP893545GFM
CSB-BP893545GFM
CSB-MP893545GFM
CSB-EP893545GFM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma gallisepticum Thymidylate synthase (thyA) CSB-YP893546MWI
CSB-EP893546MWI
CSB-BP893546MWI
CSB-MP893546MWI
CSB-EP893546MWI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodothermus marinus 60 kDa chaperonin (groL), partial CSB-YP893547RMC
CSB-EP893547RMC
CSB-BP893547RMC
CSB-MP893547RMC
CSB-EP893547RMC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella quintana Elongation factor Ts (tsf) CSB-YP893548BSH
CSB-EP893548BSH
CSB-BP893548BSH
CSB-MP893548BSH
CSB-EP893548BSH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai 30S ribosomal protein S4 (rpsD) CSB-YP893549LOS
CSB-EP893549LOS
CSB-BP893549LOS
CSB-MP893549LOS
CSB-EP893549LOS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai 50S ribosomal protein L30 (rpmD) CSB-YP893550LOS
CSB-EP893550LOS
CSB-BP893550LOS
CSB-MP893550LOS
CSB-EP893550LOS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai 50S ribosomal protein L22 (rplV) CSB-YP893551LOS
CSB-EP893551LOS
CSB-BP893551LOS
CSB-MP893551LOS
CSB-EP893551LOS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai Elongation factor Tu (tuf) CSB-YP893552LOS
CSB-EP893552LOS
CSB-BP893552LOS
CSB-MP893552LOS
CSB-EP893552LOS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a Chemotaxis protein methyltransferase (cheR) CSB-YP893553LPY
CSB-EP893553LPY
CSB-BP893553LPY
CSB-MP893553LPY
CSB-EP893553LPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alanine--tRNA ligase (alaS), partial CSB-YP893554DNW
CSB-EP893554DNW
CSB-BP893554DNW
CSB-MP893554DNW
CSB-EP893554DNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum Glutamate racemase (murI) CSB-YP893555DWY
CSB-EP893555DWY
CSB-BP893555DWY
CSB-MP893555DWY
CSB-EP893555DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Probable WRKY transcription factor 42 (WRKY42), partial CSB-YP893556DOA
CSB-EP893556DOA
CSB-BP893556DOA
CSB-MP893556DOA
CSB-EP893556DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×